JW Lifescience Corporation

₩10,460As of Sun 8 Nov 2026, 12:00 UTC
KRX:234080Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (1.75%)
Div yield 5.26%
ROE 11.91%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.19
PE TTM 6.226
TSR TTM (18.86%)
Mkt cap ₩162.0B
ROIC 10.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩11,543
10.36%
(74.98%)
Hold 5|0|8|6|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
148.99
163.49
161.66
173.29
5.30%
5.18%
2.87%
11.16%
Revenue₩B
11.54
12.13
11.80
12.03
18.23%
18.40%
9.97%
6.10%
Peers (US$119.4M)
Cap (US$)
PE
121.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.370
0.409
0.417
EBIT/Intx
0.817
0.063
0.075
Own earn%
119.22
70.36
71.45
Sh yield%
23.12
21.71
19.58
Owners
Insiders/Inst%
1.27
81.62
Short interest%
3.17
SBC / revenue%
5.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
4